VERTESS Announces Successful Transactions and Promising Outlook for 2025

FORT WORTH, Texas, May 13, 2025 /PRNewswire/ -- VERTESS (http://vertess.com), a leading healthcare mergers and acquisitions (M&A) advisory firm, is pleased to announce a strong start to 2025, marked by the successful closure of five significant transactions across various healthcare sectors. Despite the low M&A activity experienced across all industries in the past two years, VERTESS has demonstrated resilience and growth, with several more deals expected to close in the coming months.

Key Transactions:

1. Home Care Helpers (https://www.homecarehelpers.net): Acquired by Arcus Health Care (https://arcushp.com), this North Carolina home health company transaction closed in early February by Managing Director Anna Elliott. Arcus Health Care, based in New Jersey, provides skilled nursing and therapeutic services.
2. Certified Seating & Mobility: This Georgia-based durable medical equipment (DME) company was acquired by Reliable Medical Supply (https://www.reliamed.com), a Minnesota mobility company, in late February. The transaction was overseen by Managing Director Gene Quigley, who has a proven track record in DME transactions.
3. North State Medical Transport (https://www.nsmt.biz): MedTrust Holdings (https://ridemedtrust.com/), a South Carolina medical transport company, acquired this North Carolina ambulance and medical transport company. Managing Director J. Blake Peart led this deal, which closed at the beginning of March.
4. A Washington behavioral health company was acquired by Sligo Capital (https://www.sligocapital.com/), a Chicago-based private equity firm. This transaction, closed in early April, was managed by Managing Directors Dave Turgeon and Jack Turgeon.
5. Shorehaven: Acquired by Sevita (https://sevitahealth.com), a Minnesota home- and community-based healthcare company, this Maryland intellectual and developmental disability company was the second successful close by Dave Turgeon and Jack Turgeon in late April.

VERTESS remains optimistic about the remainder of 2025, with a robust pipeline of new deals and ongoing transactions. The firm is excited to see continued growth and success in the healthcare M&A sector.

"We are thrilled with the momentum we've built in the first quarter of 2025. Our team's dedication and expertise have been instrumental in closing these significant transactions," said Managing Partner Vaughne Glennie. "We look forward to continuing this trajectory and achieving even greater success throughout the year."

For more information, please contact Vaughne Glennie at [email protected] or +1.520.395.0244.  

About VERTESS  

VERTESS is an international healthcare-focused Mergers & Acquisitions (M&A) advisory firm with expertise spanning diverse healthcare and human service verticals, ranging from behavioral health and intellectual/developmental disabilities to DME, pharmacies, home care/hospice, urgent care, life sciences, and other specialized services and products. Each VERTESS Managing Director has had executive experience in either launching or managing and ultimately successfully exiting a healthcare company.  

SOURCE Vertess Healthcare Advisors, LLC